Dieter Wiedenmayer
Dieter Wiedenmayer, Biberach DE
Patent application number | Description | Published |
---|---|---|
20100240669 | NEW COMPOUNDS - The present invention relates to the compounds of general formula I | 09-23-2010 |
20110212102 | HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 09-01-2011 |
20110212103 | THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-01-2011 |
20110217311 | CYCLOALKYL CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-08-2011 |
20110275625 | Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors - Disclosed are compounds and compositions of the formula (I) as described herein which are inhibitors of MMP-13. Also disclosed are methods of using and making compounds of the formula (I). | 11-10-2011 |
20120142695 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS - Compounds of the formula I | 06-07-2012 |
20130131075 | NEW COMPOUNDS - The present invention relates to the compounds of general formula I | 05-23-2013 |
Dieter Wiedenmayer, Biberach An Der Riss DE
Patent application number | Description | Published |
---|---|---|
20140135309 | SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS - This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I | 05-15-2014 |
20150045326 | NOVEL PYRAZINE AMIDE COMPOUNDS - The present invention relates to compounds of formula 1 or pharmaceutically acceptable salt thereof, | 02-12-2015 |